Everest Medicines Limited (1952.HK)

HKD 49.7

(1.84%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 5.77 Billion 6.61 Billion 6.64 Billion 7.47 Billion 2.13 Billion 723.17 Million
Total Current Assets 2.5 Billion 3.41 Billion 2.68 Billion 4.49 Billion 131.15 Million 209.81 Million
Cash And Short Term Investments 2.34 Billion 1.65 Billion 2.64 Billion 4.48 Billion 106.06 Million 183.5 Million
Cash and Cash Equivalents 523.06 Million 490.78 Million 2.64 Billion 4.48 Billion 106.06 Million 183.5 Million
Short Term Investments 1.82 Billion 1.16 Billion - 2.08 Million 161 Thousand 392 Thousand
Net Receivables 49.85 Million 1.75 Billion 47.37 Million - - -
Inventory 18.94 Million 11.63 Million 447 Thousand - - -
Other Current Assets 916 Thousand 27 Thousand 50 Thousand 909 Thousand 159 Thousand 150 Thousand
Total Non-Current Assets 3.26 Billion 3.2 Billion 3.95 Billion 2.98 Billion 2 Billion 513.35 Million
Net PPE 651.45 Million 690.51 Million 253.79 Million 86.69 Million 46.07 Million 18.67 Million
Good Will And Intangible Assets 2.55 Billion 2.41 Billion 2.85 Billion 2.04 Billion 1.66 Billion 493.46 Million
Good Will - - - - - -
Intangible Assets 2.55 Billion 2.41 Billion 2.85 Billion 2.04 Billion 1.66 Billion 493.46 Million
Long-Term Investments 48.93 Million -1.07 Billion 830.4 Million 845.69 Million 34.88 Million -
Tax Assets -619 Thousand 1.07 Billion -830.4 Million -845.69 Million -34.88 Million -
Other Non Current Assets 8.52 Million 97.73 Million 853.94 Million 852.74 Million 296.26 Million 1.21 Million
Other Assets - - - - - -
Total Liabilities 804.1 Million 960.25 Million 753.82 Million 636.11 Million 2.99 Billion 1.67 Billion
Total Current Liabilities 300.12 Million 870.02 Million 270.26 Million 186.91 Million 503.87 Million 159.92 Million
Account Payables 48.89 Million 44.49 Million 54.25 Million 40.72 Million 40.05 Million 1.64 Million
Tax Payables 3.72 Million 5.96 Million 4.97 Million 3.67 Million 1.49 Million -
Short Term Debt 41.31 Million 444.4 Million 28.25 Million 19.01 Million 10.54 Million 5.82 Million
Deferred Revenue 27.93 Million - - - - -
Other Current Liabilities 181.98 Million 381.12 Million 187.76 Million 127.17 Million 453.27 Million 152.45 Million
Total Non Current Liabilities 503.97 Million 90.23 Million 483.56 Million 449.19 Million 2.49 Billion 1.51 Billion
Long-Term Debt 469.31 Million 59.3 Million 456.78 Million 428.31 Million 30.21 Million 10.91 Million
Deferred Revenue Non Current 6.05 Million - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 6.05 Million 30.92 Million 26.77 Million 20.88 Million 2.46 Billion 1.49 Billion
Other Liabilities - - - - - -
Total Equity 4.96 Billion 5.65 Billion 5.89 Billion 6.84 Billion -861.08 Million -947.56 Million
Stock Holders Equity 4.96 Billion 5.65 Billion 5.89 Billion 6.84 Billion -861.08 Million -947.56 Million
Common Stock 219 Thousand 211 Thousand 202 Thousand 198 Thousand 17 Thousand 2000.00
Retained Earnings -9.01 Billion -8.17 Billion -7.92 Billion -6.91 Billion -1.25 Billion -1.04 Billion
Accumulated other comprehensive income 13.98 Billion 13.82 Billion 13.87 Billion 13.75 Billion 396.75 Million -5.28 Million
Common Stock Equity 4.96 Billion 5.65 Billion 5.89 Billion 6.84 Billion -861.08 Million -947.56 Million
Capital Lease Obligation 58.64 Million 79.63 Million 124.1 Million 77.89 Million 40.75 Million 16.73 Million
Total Investments 48.93 Million 89.24 Million 830.4 Million 845.69 Million 34.88 Million 392 Thousand
Total Debt 510.62 Million 503.71 Million 485.03 Million 447.33 Million 40.75 Million 16.73 Million
Net Debt -12.43 Million 12.92 Million -2.15 Billion -4.03 Billion -65.3 Million -166.76 Million

Balance Sheet Charts